Scoggin Management’s AbbVie ABBV Stock Holding History

Scoggin Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-196,500	Closed	-$13.2M	–	49
2015 Q2	$13.2M	Sell	196,500 -171,500	-47%	-$11.2M	1.15%	28
2015 Q1	$21.5M	Buy	+368,000	New	+$22.2M	1.74%	23
2014 Q4	–	Sell	-200,000	Closed	-$11.6M	–	82
2014 Q3	$11.6M	Buy	+200,000	New	+$11.1M	0.61%	45

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Scoggin Management's ABBV Position: Q3 2015 in Review

Scoggin Management sold out of AbbVie (ABBV) in Q3 2015, closing a stake of 393,000 shares — an estimated $26.4M sold.

Scoggin Management first reported a position in ABBV in Q4 2013 and held it in 7 quarters. The position peaked at $37.6M in Q2 2014. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

Scoggin Management reported no remaining AbbVie position as of Q3 2015 after selling out during the quarter.
Scoggin Management sold 393,000 AbbVie shares in Q3 2015, an estimated $26.4M.
Scoggin Management first reported a position in AbbVie in Q4 2013 and held it in 7 quarters.
Scoggin Management's AbbVie position peaked at $37.6M in Q2 2014.
1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Scoggin Management's 13F filing for Q3 2015, filed 13 Nov 2015.